Evidence from systematic reviews on policy approaches to improving access to medicines

The prevailing frameworks on access to medicines advise global procurement as a solution by assuming the presence of medicines on the global market. Yet access to medicines remains challenging, especially in developing countries. This is a global worry because the UN considers limited access to ess...

Full description

Bibliographic Details
Main Authors: Celestino Kuchena, Abubaker Qutieshat
Format: Article
Language:English
Published: PAGEPress Publications 2023-07-01
Series:Healthcare in Low-resource Settings
Subjects:
Online Access:https://www.pagepressjournals.org/index.php/hls/article/view/11143
_version_ 1797224707744858112
author Celestino Kuchena
Abubaker Qutieshat
author_facet Celestino Kuchena
Abubaker Qutieshat
author_sort Celestino Kuchena
collection DOAJ
description The prevailing frameworks on access to medicines advise global procurement as a solution by assuming the presence of medicines on the global market. Yet access to medicines remains challenging, especially in developing countries. This is a global worry because the UN considers limited access to essential medicines as one of the five indicators of securing the right to health. To fill a research gap in health system studies and inform policymaking, we synthesized evidence from systematic reviews of how government policies affect low- and middle-income country (LMIC) medicine access. We chose a rapid review approach to reduce timelines and avoid missing policy “windows of opportunity.” To include only studies published after the start of COVID-19, we chose systematic reviews published between 2019 and November 2nd, 2022. This was also in line with recommendations in the literature to look at recent systematic reviews. The themes were grouped using a thematic and textual narrative approach. This review included 32 studies that examined access to medicine from various perspectives. Both supply- and demand-side policies are needed to improve medical access. LMICs cannot afford medicines, and supply never meets demand. LMICs will continue to struggle with pharmaceutical pricing due to their limited bargaining power. The urban bias in health facilities and policy changes reduce medicine availability and use. Leaders must make policy decisions to sustain domestic funds. Policymakers should consider that organizations may act against policy goals. Instead of copying developed nations, LMIC governments must develop multipronged strategies to address their unique challenges.
first_indexed 2024-04-24T13:57:24Z
format Article
id doaj.art-f5b026d715a846fbb9a07174549c411c
institution Directory Open Access Journal
issn 2281-7824
language English
last_indexed 2024-04-24T13:57:24Z
publishDate 2023-07-01
publisher PAGEPress Publications
record_format Article
series Healthcare in Low-resource Settings
spelling doaj.art-f5b026d715a846fbb9a07174549c411c2024-04-03T17:28:46ZengPAGEPress PublicationsHealthcare in Low-resource Settings2281-78242023-07-0111110.4081/hls.2023.11143Evidence from systematic reviews on policy approaches to improving access to medicinesCelestino Kuchena0Abubaker Qutieshat1Business and Management Department, University of Zambia, LusakaResearch Department, Oman Dental College, Muscat The prevailing frameworks on access to medicines advise global procurement as a solution by assuming the presence of medicines on the global market. Yet access to medicines remains challenging, especially in developing countries. This is a global worry because the UN considers limited access to essential medicines as one of the five indicators of securing the right to health. To fill a research gap in health system studies and inform policymaking, we synthesized evidence from systematic reviews of how government policies affect low- and middle-income country (LMIC) medicine access. We chose a rapid review approach to reduce timelines and avoid missing policy “windows of opportunity.” To include only studies published after the start of COVID-19, we chose systematic reviews published between 2019 and November 2nd, 2022. This was also in line with recommendations in the literature to look at recent systematic reviews. The themes were grouped using a thematic and textual narrative approach. This review included 32 studies that examined access to medicine from various perspectives. Both supply- and demand-side policies are needed to improve medical access. LMICs cannot afford medicines, and supply never meets demand. LMICs will continue to struggle with pharmaceutical pricing due to their limited bargaining power. The urban bias in health facilities and policy changes reduce medicine availability and use. Leaders must make policy decisions to sustain domestic funds. Policymakers should consider that organizations may act against policy goals. Instead of copying developed nations, LMIC governments must develop multipronged strategies to address their unique challenges. https://www.pagepressjournals.org/index.php/hls/article/view/11143Accessaffordabilityavailabilitymedicinespolicy
spellingShingle Celestino Kuchena
Abubaker Qutieshat
Evidence from systematic reviews on policy approaches to improving access to medicines
Healthcare in Low-resource Settings
Access
affordability
availability
medicines
policy
title Evidence from systematic reviews on policy approaches to improving access to medicines
title_full Evidence from systematic reviews on policy approaches to improving access to medicines
title_fullStr Evidence from systematic reviews on policy approaches to improving access to medicines
title_full_unstemmed Evidence from systematic reviews on policy approaches to improving access to medicines
title_short Evidence from systematic reviews on policy approaches to improving access to medicines
title_sort evidence from systematic reviews on policy approaches to improving access to medicines
topic Access
affordability
availability
medicines
policy
url https://www.pagepressjournals.org/index.php/hls/article/view/11143
work_keys_str_mv AT celestinokuchena evidencefromsystematicreviewsonpolicyapproachestoimprovingaccesstomedicines
AT abubakerqutieshat evidencefromsystematicreviewsonpolicyapproachestoimprovingaccesstomedicines